button_search2

Tumor

Disclaimer
Copyright 2007
Eigenbrodt / Mazurek
Webdesign and
Webserver by
onSite

Tumor M2-PK:

a tool for metabolic profiling of
renal tumors

 

Enzymatic measurements revealed an increase in pyruvate kinase vmax activities in renal clear-cell carcinomas (RCCs) compared to normal renal cortex taken from the same patient.

 

 

Vmax activities of pyruvate kinase
in homogenates
of normal renal cortex and RCCs
 

renal_tumors_homogenates02


Vmax activities were measured spectrophotometrically according to the following
reaction:

lung_cancer_reaction03

 

 

In normal renal tissues immunohistochemical localization of PK isoenzymes reveals a selective expression of pyruvate kinase type L (L-PK) in the epithelia of the proximal tubules whereas the pyruvate kinase isoenzyme type M2 (M2-PK) is only detectable in distal tubules, the loops of Henle and collecting tubules.

 

renal_tubules_L-pk_staining

 

L-PK staining in

 

proximal renal tubules


 

 

renal_tubules_M2-PK_stainin

 

M2-PK staining in

 

distal renal tubules


 

 

renal_medulla_M2-PK_stainin

 

M2-PK staining in

 

the loops of Henle and

 

collecting tubules of

 

the renal medulla


 

 

Renal cell carcinomas of clear cells and chromophilic cells are characterized by a homogeneous expression of M2-PK and a heterogeneous expression of L-PK.


 

 

L-PK_staining_in_RCCs

 

L-PK staining

 

in RCCs


 

 

M2-PK_staining_in_RCCs02

 

M2-PK staining

 

in RCCs

 

The observation that L-PK, which is a specific proximal renal tubule differentiation molecule, is expressed in clear-cell and chromophilic RCCs provides further evidence that the majority of clear cells and chromophilic RCCs in humans derive from proximal tubules.

Immunohistochemical staining of PK isoenzymes: Gösta Fischer

 

 

 

Tumor M2-PK concentrations
in EDTA-plasma samples
from patients with renal clear-cell carcinomas
Correlation between Tumor M2-PK values and staging

tumor_M2-PK_concentrations

By courtesy of : Gerhard Maximilian Oremek

 

 

 

Tumor M2-PK concentrations
in EDTA-plasma samples

Follow-up study of a patient with a RCC with metastases
Complete Remission

tumor_M2-PK_concentrations_

By courtesy of : Hans Wilhelm Wechsel

 

 

Tumor M2-PK concentrations were measured with a sandwich ELISA from
ScheBo ˇ Biotech AG, Giessen, Germany.

 

References

Tumor M2-PK: Clinical relevance for metabolic profiling of tumors

Pyruvate kinase isoenzymes: M2-PK

Metabolic tools for tumor diagnosis

[Home] [Overview] [Glycolysis] [Glutaminolysis] [Nucleogenesis] [Serinolysis] [Lipogenesis] [tumor_metabolome_key_metabolites] [Nutrients] [Oncoproteins] [tumor_diagnosis] [Animations]